Vor Biopharma VOR

$ 13.28 -0.08%

Quarterly report 2026-Q1
added 05-13-2026

Country	USA
IPO year	2021
Industry	-
Stock Exchange	NASDAQ GLOBAL

Shares	9.87 M
Market Cap^[1]	$ 131 M
EBITDA (LTM)	$ -367 M
P/E (LTM)	-0.11
P/S (LTM)	-
EPS (LTM)	-139.56

References

Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.